Skip to main content
logo
Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
25.51
-0.71 (-2.71%)
Sep 22, 2026, 4:00 PM EDT - Market closed

Apnimed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,062----
Market Cap Growth
-----
Enterprise Value
970----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
1.15-0.27-0.02-0.00
Net Debt / Equity Ratio
-1.320.001.54-2.70-1.01
Net Debt / EBITDA Ratio
-2.580.010.593.59-
Net Debt / FCF Ratio
1.320.010.61-6.865.12
Asset Turnover
-0.420.05--
Quick Ratio
4.880.391.648.6238.60
Current Ratio
5.190.411.738.7439.22
Return on Equity (ROE)
---1045.65%-81.46%-
Return on Assets (ROA)
--36.94%-44.17%-17.33%-
Return on Capital Employed (ROCE)
22.40%141.60%-170.80%-25.00%-20.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Buyback Yield / Dilution
-562.85%-0.49%-86.29%-21.39%-
SEC Filings: 10-K · 10-Q